Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticlePET/CT in Cancer Patient Management

Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma

Andrew Quon, Nancy J. Fischbein, I. Ross McDougall, Quynh-Thu Le, Billy W. Loo, Harlan Pinto and Michael J. Kaplan
Journal of Nuclear Medicine January 2007, 48 (1 suppl) 58S-67S;
Andrew Quon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy J. Fischbein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Ross McDougall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Quynh-Thu Le
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Billy W. Loo Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harlan Pinto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Kaplan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

FIGURE 10. 

FIGURE 10. 
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 10. 

18F-FDG PET/CT for detecting scintigraphically occult metastatic thyroid cancer. Patient had persistently elevated Tg levels after thyroidectomy and 131I ablation. (A) Whole-body 131I scan appeared normal and did not reveal source of abnormal Tg production. (B and C) Follow-up 18F-FDG PET/CT detected several paratracheal lymph node metastases (red arrow) and lung metastasis (yellow arrow).

  View article

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FIGURE 10. 
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma
Andrew Quon, Nancy J. Fischbein, I. Ross McDougall, Quynh-Thu Le, Billy W. Loo, Harlan Pinto, Michael J. Kaplan
Journal of Nuclear Medicine Jan 2007, 48 (1 suppl) 58S-67S;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma
Andrew Quon, Nancy J. Fischbein, I. Ross McDougall, Quynh-Thu Le, Billy W. Loo, Harlan Pinto, Michael J. Kaplan
Journal of Nuclear Medicine Jan 2007, 48 (1 suppl) 58S-67S;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • CT Texture Analysis of Cervical Lymph Nodes on Contrast-Enhanced [18F] FDG-PET/CT Images to Differentiate Nodal Metastases from Reactive Lymphadenopathy in HIV-Positive Patients with Head and Neck Squamous Cell Carcinoma
  • Effects of Intratumoral Inflammatory Process on 18F-FDG Uptake: Pathologic and Comparative Study with 18F-Fluoro-{alpha}-Methyltyrosine PET/CT in Oral Squamous Cell Carcinoma
  • Usefulness of 3'-Deoxy-3'-18F-Fluorothymidine PET for Predicting Early Response to Chemoradiotherapy in Head and Neck Cancer
  • 18F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging
  • Fluorodeoxyglucose-Positron-Emission Tomography Imaging of Head and Neck Squamous Cell Cancer
  • PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
  • Tumor Volume Assessment by 18F-FDG PET/CT in Patients with Oral Cavity Cancer with Dental Artifacts on CT or MR Images
  • Introduction
  • Google Scholar

More in this TOC Section

  • Improvements in Cancer Staging with PET/CT: Literature-Based Evidence as of September 2006
  • Integrating PET and PET/CT into the Risk-Adapted Therapy of Lymphoma
  • Commentary
Show more PET/CT in Cancer Patient Management

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire